Acute Myeloid Leukemia With Minimal Differentiation: Disease Bioinformatics
Acute Myeloid Leukemia is a clonal disorder caused by malignant transformation of a bone marrow-derived, self-renewing stem cell or progenitor. This leads to a decreased rate of self-destruction and aberrant differentiation causing an accumulation in the organs and bone marrow by these myeloid cells. When there is no evidence of myeloid differentiation, the disease is categorized as having minimal differentiation. The development of Acute Myeloid Leukemia has been associated with many predisposition syndromes that are caused by chromosomal imbalances, DNA repair defects, altered protein synthesis and altered cytokine receptors or signal transduction pathways.
Acute Myeloid Leukemia With Minimal Differentiation Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Acute Myeloid Leukemia With Minimal Differentiation below!
For more information on how to use Laverne, please read the How to Guide.
We have 2267 products for the study of Acute Myeloid Leukemia With Minimal Differentiation that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Acute Myeloid Leukemia With Minimal Differentiation is also known as Acute Myeloblastic Leukemia M0, Acute Myelogenous Leukemia With Minimal Differentiation, Acute Myeloid Leukaemia With Minimal Differentiation, Aml With Minimal Differentiation, Fab M0.